ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $309,000 | +36.1% | 89,900 | 0.0% | 0.00% | – |
| Q4 2020 | $227,000 | +19.5% | 89,900 | 0.0% | 0.00% | – |
| Q3 2020 | $190,000 | -5.5% | 89,900 | 0.0% | 0.00% | – |
| Q2 2020 | $201,000 | +39.6% | 89,900 | +57.9% | 0.00% | – |
| Q1 2020 | $144,000 | -4.0% | 56,941 | 0.0% | 0.00% | – |
| Q4 2019 | $150,000 | -26.8% | 56,941 | 0.0% | 0.00% | – |
| Q3 2019 | $205,000 | +6.8% | 56,941 | 0.0% | 0.00% | – |
| Q2 2019 | $192,000 | +23.9% | 56,941 | 0.0% | 0.00% | – |
| Q1 2019 | $155,000 | -1.9% | 56,941 | 0.0% | 0.00% | – |
| Q4 2018 | $158,000 | -32.8% | 56,941 | 0.0% | 0.00% | – |
| Q3 2018 | $235,000 | -32.3% | 56,941 | -14.9% | 0.00% | – |
| Q2 2018 | $347,000 | -5.4% | 66,936 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $367,000 | -29.7% | 66,936 | +4.6% | 0.00% | 0.0% |
| Q4 2017 | $522,000 | -42.1% | 64,014 | -25.6% | 0.00% | 0.0% |
| Q3 2017 | $901,000 | +43.2% | 86,034 | +51.1% | 0.00% | 0.0% |
| Q2 2017 | $629,000 | +31.9% | 56,941 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $477,000 | +20.8% | 56,941 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $395,000 | +36.2% | 56,941 | 0.0% | 0.00% | – |
| Q3 2016 | $290,000 | -51.5% | 56,941 | -43.1% | 0.00% | -100.0% |
| Q2 2016 | $598,000 | +130.9% | 100,141 | +75.9% | 0.00% | – |
| Q1 2016 | $259,000 | +1.2% | 56,941 | 0.0% | 0.00% | – |
| Q4 2015 | $256,000 | +41.4% | 56,941 | 0.0% | 0.00% | – |
| Q3 2015 | $181,000 | +4.6% | 56,941 | 0.0% | 0.00% | – |
| Q2 2015 | $173,000 | -11.3% | 56,941 | 0.0% | 0.00% | – |
| Q1 2015 | $195,000 | 0.0% | 56,941 | 0.0% | 0.00% | – |
| Q4 2014 | $195,000 | -33.4% | 56,941 | 0.0% | 0.00% | – |
| Q3 2014 | $293,000 | -2.0% | 56,941 | 0.0% | 0.00% | – |
| Q2 2014 | $299,000 | +29.4% | 56,941 | 0.0% | 0.00% | – |
| Q1 2014 | $231,000 | +40.0% | 56,941 | 0.0% | 0.00% | – |
| Q4 2013 | $165,000 | +15.4% | 56,941 | 0.0% | 0.00% | – |
| Q3 2013 | $143,000 | +21.2% | 56,941 | 0.0% | 0.00% | – |
| Q2 2013 | $118,000 | – | 56,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |